Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Isoray Inc (ISR)

Isoray Inc (ISR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,571
  • Shares Outstanding, K 142,113
  • Annual Sales, $ 10,800 K
  • Annual Income, $ -7,270 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.48
  • Price/Sales 5.05
  • Price/Cash Flow N/A
  • Price/Book 0.95
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings $-0.03 on 11/10/22
  • Next Earnings Date 02/14/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.01
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2699 +42.27%
on 01/20/23
0.4400 -12.73%
on 02/06/23
+0.1038 (+37.04%)
since 01/17/23
3-Month
0.2393 +60.47%
on 12/28/22
0.4400 -12.73%
on 02/06/23
+0.0090 (+2.40%)
since 11/17/22
52-Week
0.1922 +99.79%
on 09/29/22
0.4499 -14.65%
on 08/18/22
+0.0157 (+4.26%)
since 02/17/22

Most Recent Stories

More News
Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine

Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced the successful completion of the merger with privately-held Viewpoint Molecular Targeting,...

ISR : 0.3840 (+0.03%)
ISORAY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Isoray, Inc - ISR

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Isoray, Inc (“the Company”) (NYSE: ISR)...

ISR : 0.3840 (+0.03%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TALO, ISR, FCRD, SESN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TALO : 9.23 (+1.65%)
ISR : 0.3840 (+0.03%)
FCRD : 4.54 (-3.61%)
SESN : 12.5760 (+7.29%)
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT

Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, and Viewpoint Molecular Targeting, Inc., a radiopharmaceutical company developing precision lead-212-based...

ISR : 0.3840 (+0.03%)
ISR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Isoray, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Isoray, Inc. (NYSE: ISR) and Viewpoint Molecular Targeting, Inc. is fair to Isoray shareholders.

ISR : 0.3840 (+0.03%)
Inflation Report Due in Canada Next Week

Monday U.S. Economic Lookahead NAHB home builders' index (Sept.) Featured Earnings Autozone ...

AZO : 3,283.48 (+1.27%)
NEOG : 12.22 (+0.83%)
APOG : 72.07 (+1.19%)
SFIX : 3.77 (-1.82%)
ISR : 0.3840 (+0.03%)
GIS : 63.74 (+0.30%)
LEN : 138.00 (unch)
TCOM : 72.31 (-0.97%)
COST : 958.82 (+0.94%)
ACN : 361.63 (+0.80%)
FDX : 271.84 (+1.05%)
INM : 4.66 (-0.43%)
Isoray’s Cesium-131 Featured in Presentations at American Brachytherapy Society’s Annual Conference

RICHLAND, Wash., June 21, 2022 (GLOBE NEWSWIRE) -- The growing body of information regarding Isoray, Inc.’s (NYSE American: ISR) Cesium-131 in treating...

ISR : 0.3840 (+0.03%)
Isoray To Host Lunch Symposium At American Brachytherapy Society’s Annual Conference

RICHLAND, Wash., June 15, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy,...

ISR : 0.3840 (+0.03%)
Isoray Announces Record Third Quarter Fiscal 2022 Financial Results

Revenue Increased 12% Year-Over-YearRecord Non-Prostate Brachytherapy Revenue Increased 28% Year-Over-Year RICHLAND, Wash., May 10, 2022 (GLOBE...

ISR : 0.3840 (+0.03%)
Isoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022

Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. ...

ISR : 0.3840 (+0.03%)

Business Summary

IsoRay, Inc. is a medical technology company that produces therapeutic radioactive isotopes. Through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the...

See More

Key Turning Points

3rd Resistance Point 0.4243
2nd Resistance Point 0.4071
1st Resistance Point 0.3956
Last Price 0.3840
1st Support Level 0.3669
2nd Support Level 0.3497
3rd Support Level 0.3382

See More

52-Week High 0.4499
Last Price 0.3840
Fibonacci 61.8% 0.3515
Fibonacci 50% 0.3210
Fibonacci 38.2% 0.2906
52-Week Low 0.1922

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar